Investigating ways to delay the onset of nearsightedness in children
Feasibility of study to delay myopia onset
This study is looking for ways to help kids aged 6 to 11 who might develop nearsightedness by testing if low concentration atropine eye drops can slow it down before it starts, which could help keep their eyes healthy as they grow up.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10691555 on NIH RePORTER |
What this research studies
This research focuses on finding effective methods to delay the onset of myopia, particularly in children aged 6 to 11 who are at risk of developing this condition. The study will explore the feasibility of using low concentration atropine eye drops to potentially slow down the progression of myopia before it begins. By assessing the ability to enroll participants and conduct a future clinical trial, the research aims to establish a foundation for preventing myopia-related complications in adulthood. If successful, this could lead to significant improvements in eye health and quality of life for children.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 6 to 11 who are at risk of developing myopia.
Not a fit: Patients who are already diagnosed with myopia or are older than 11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could help reduce the risk of developing severe myopia and its associated complications in children.
How similar studies have performed: Previous studies have shown promising results with atropine in controlling myopia, indicating that this approach has potential based on existing evidence.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Walline, Jeffrey Jay — Ohio State University
- Study coordinator: Walline, Jeffrey Jay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.